Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis

被引：0
|
作者：
Shell, J. [1 ]
Kapralik, J. [2 ]
Jones, A. [3 ]
Farooqi, M. [2 ]
Beattie, K. [4 ]
Kolb, M. R. [2 ]
Cox, G. P. [2 ]
Scallan, C. J. [5 ]
Larche, M. J. [4 ]
Khalidi, N. A. [4 ]
Hambly, N. [5 ]
机构：
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] McMaster Univ, Div Respirol, Dept Med, Hamilton, ON, Canada
[3] McMaster Univ, Dept Hlth Res Methods, Hamilton, ON, Canada
[4] McMaster Univ, Div Rheumatol, Dept Med, Hamilton, ON, Canada
[5] McMaster Univ, Respirol, Hamilton, ON, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1915
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A RANDOMISED CONTROLLED TRIAL TO COMPARE THE EFFICACY OF ORAL MYCOPHENOLATE MOFETIL WITH PLACEBO IN PATIENTS WITH SYSTEMIC SCLEROSIS RELATED EARLY INTERSTITIAL LUNG DISEASE
    Naidu, G.
    Sharma, S.
    Dhir, V.
    Dhooria, S.
    Sinha, A.
    Mb, A.
    Jain, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 751 - 752
  • [42] Interstitial Lung Disease Associated with Systemic Sclerosis
    Mismetti, Valentine
    Si-Mohamed, Salim
    Cottin, Vincent
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 342 - 364
  • [43] A Randomized Controlled Trial to Compare the Efficacy and Safety of Tacrolimus with Mycophenolate Mofetil in Patients with Systemic Sclerosis - Interstitial Lung Disease ( INSIST TRIAL)
    Sharma, Shefali Khanna
    Mathew, Jithin
    Kopp, Chirag
    Dhir, Varun
    Dhooria, Sahajal
    Sinha, Anindita
    Jain, Sanjay
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5172 - 5174
  • [44] Systemic Sclerosis Associated Interstitial Lung Disease
    Steen, Virginia
    Weir, Nargues
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2015, 11 (02) : 110 - 118
  • [45] Systemic sclerosis associated interstitial lung disease
    Xanthouli, P.
    Hermann, W.
    Hunzelmann, N.
    Kreuter, M.
    PNEUMOLOGE, 2018, 15 (06): : 383 - 395
  • [46] THERAPEUTIC STRATEGY COMBINING INTRAVENOUS CYCLOPHOSPHAMIDE FOLLOWED BY ORAL MYCOPHENOLATE MOFETIL TO TREAT SEVERE OR WORSENING INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Duchange, Al
    Mouthon, L.
    Berezne, A.
    Morell-Dubois, S.
    Hatron, P. Y.
    Guillevin, L.
    Hachulla, E.
    Launay, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S165 - S165
  • [47] Effects Of Mycophenolate Mofetil In Connective Tissue Disease-Associated Interstitial Lung Disease
    Takada, T.
    Asakawa, K.
    Sakagami, T.
    Moriyama, H.
    Narita, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [48] Interstitial lung disease in systemic sclerosis - Treatment
    Hellmich, B
    Schnabel, A
    Bauer, T
    Schatz, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (10) : 520 - 522
  • [49] MYCOPHENOLATE MOFETIL VERSUS AZATHIOPRINE IN SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE: RESULTS FROM THE AUSTRALIAN SCLERODERMA COHORT STUDY
    Owen, C.
    Ngian, G.
    Moore, O.
    Stevens, W.
    Proudman, S.
    Roddy, J.
    Zochling, J.
    Nash, P.
    Hill, C.
    Sturgess, A.
    Sahhar, J.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 36 - 36
  • [50] Current treatment of systemic sclerosis-associated interstitial lung disease
    Bes, Cemal
    Cetinkaya, Erdogan
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2022, 70 (01): : 85 - 92
12345